The FDA has granted fast track designation to emiltatug ledadotin for advanced or metastatic breast cancer treatment, as ...

Amgen (AMGN) stock in focus as U.S. approval for its lung cancer drug expands for metastatic colorectal cancer. Read more ...

Tumor invasion and angiogenesis ... Our results indicate that EGCG, as direct inhibitor of MMPs, inhibits angiogenesis and metastasis upstream of the action of angiogenesis inhibitors derived ...

AI Innovation Unlocks Non-Surgical Way to Detect Brain Cancer Spread Jan. 14 ... with a clinically investigative glutamine metabolism inhibitor, CB-839, can overcome tumor resistance and ...

New study successfully made CTC-derived organoids from breast cancer patients' blood samples to investigate cell survival and ...

The US regulator has cleared Lumakras (sotorasib) in combination with Amgen's anti-EGFR antibody Vectibix (panitumumab) for ...

These findings have given iOnctura confidence for an ongoing AION-02 study with standard chemotherapy in metastatic pancreatic cancer patients ... action of checkpoint inhibitor drugs.

Unlocking the Secrets of Cancer Metastasis: Study Provides New Insights, Potential Therapeutic Opportunities Oct. 30, 2024 — Metastasis remains the primary challenge to reducing cancer deaths ...

Announcing a new publication for Acta Materia Medica journal. Epithelial cell adhesion molecule (EpCAM) is a biomarker for ...

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells ...

In the last few years, large Phase III trials showed improvements in survival and outcomes and led to the approval of a CYP17 inhibitor ... Metastatic castration-resistant prostate cancer ...

FFECTOR Therapeutics (NASDAQ:EFTR – Get Free Report) will likely be posting its quarterly earnings results on Tuesday, January 21st. Analysts expect eFFECTOR Therapeutics to post earnings of ($2.02) ...